Slide Insurance (SLDE) risk chief exercises options, sells 16,250 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Slide Insurance Holdings Chief Risk Officer Matthew Paul Larson executed an options exercise-and-sale transaction in company stock. On May 18, 2026, he exercised stock options to acquire 16,250 shares of common stock at an exercise price of $0.79 per share, then sold the same 16,250 shares in open-market trades at a weighted average price of $19.01 per share.
The sale prices ranged from $18.83 to $19.21 per share and was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 4, 2025. Following these transactions, Larson holds 0 shares of common stock directly and 22,748 stock options that are fully vested and exercisable, expiring on February 24, 2032.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 16,250 shares ($308,913)
Net Sell
3 txns
Insider
LARSON MATTHEW PAUL
Role
Chief Risk Officer
Sold
16,250 shs ($309K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 16,250 | $0.00 | -- |
| Exercise | Common Stock | 16,250 | $0.79 | $13K |
| Sale | Common Stock | 16,250 | $19.01 | $309K |
Holdings After Transaction:
Stock Option (Right to Buy) — 22,748 shares (Direct, null);
Common Stock — 16,250 shares (Direct, null)
Footnotes (1)
- Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.83 to $19.21 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. These stock options are fully vested and exercisable.
Key Figures
Shares sold: 16,250 shares
Sale price (weighted average): $19.01 per share
Sale price range: $18.83–$19.21 per share
+4 more
7 metrics
Shares sold
16,250 shares
Open-market sale of common stock on May 18, 2026
Sale price (weighted average)
$19.01 per share
Average price for 16,250 shares sold
Sale price range
$18.83–$19.21 per share
Price range of individual trades on May 18, 2026
Option exercise price
$0.79 per share
Stock Option (Right to Buy) conversion price
Shares acquired via exercise
16,250 shares
Common stock obtained from option exercise on May 18, 2026
Common shares held after
0 shares
Direct common stock holdings following transactions
Options remaining
22,748 options
Fully vested and exercisable, expiring February 24, 2032
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Buy), fully vested and exercisable
4 terms
Rule 10b5-1 trading plan regulatory
"Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"Represents the weighted average price of the shares sold."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
fully vested and exercisable financial
"These stock options are fully vested and exercisable."
FAQ
What insider transaction did SLDE Chief Risk Officer Matthew Paul Larson report?
Matthew Paul Larson reported an exercise-and-sale transaction involving 16,250 Slide Insurance common shares. He exercised stock options at $0.79 per share and sold the same 16,250 shares in open-market trades at a weighted average price of $19.01 per share on May 18, 2026.
Was the SLDE insider sale by Matthew Paul Larson under a Rule 10b5-1 plan?
Yes. The filing states the options were exercised and the resulting shares sold pursuant to a Rule 10b5-1 trading plan. That plan was adopted by Matthew Paul Larson on December 4, 2025, indicating the trades were pre-arranged rather than discretionary on the trade date.
What type of derivative security did Matthew Paul Larson exercise in this SLDE Form 4?
He exercised a stock option described as a "Stock Option (Right to Buy)" with a conversion or exercise price of $0.79 per share. The option is fully vested and exercisable and, after the transaction, 22,748 option shares remain outstanding, expiring on February 24, 2032.